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Reduced foot clearance when walking may increase the risk of trips and falls in people with Parkinson’s
disease (PD). Changes in foot clearance in people with PD are likely to be associated with temporal-spatial
characteristics of gait such as walking slowly which evokes alterations in the temporal-spatial control of
stepping patterns. Enhancing our understanding of the temporal-spatial determinants of foot clearance
may inform the design of falls prevention therapies.
Thirty-six people with PD and 38 age-matched controls completed four intermittent walks under two
conditions: self-selected and fast gait velocity. Temporal-spatial characteristics of gait and foot (heel and
toe) clearance outcomes were obtained using an instrumented walkway and 3D motion capture, respec-
tively. A general linear model was used to quantify the effect of PD and gait velocity on gait and foot
clearance. Regression evaluated the temporal and spatial gait predictors of minimum toe clearance
(MTC).
PD walked slower regardless of condition (p = .016) and tended to increase their step length to achieve
a faster gait velocity. Step length and the walk ratio consistently explained the greatest proportion of
variance in MTC (>28% and >33%, respectively) regardless of group or walking condition (p < .001).
Our results suggest step length is the primary determinant of MTC regardless of pathology.
Interventions that focus on increasing step length may help to reduce the risk of trips and falls during
gait, however, clinical trials are required for robust evaluation.
 2018 The Authors. Published by Elsevier Ltd. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
Discrete modifications to step length and step time (or rate of
steps; cadence) allow us to maintain an appropriate velocity for
a given environment. Both the temporal and spatial control of gait
is altered in people with Parkinson’s disease (PD) beyond that of
normal ageing. People with PD walk more slowly, with a shorter
step length and slower rate of steps, compared to age-matched
controls (Morris et al., 1996; Carpinella et al., 2007; Galna et al.,2015). PD affects 1% of adults aged 60 years (de Lau and
Breteler, 2006) and gait alterations are common (Morris et al.,
1996; Hass et al., 2012; Galna et al., 2015) due to a range of motor
impairments, including a reduced magnitude (hypokinesia) and
speed (bradykinesia) of movement, axial rigidity and postural
instability (Bloem et al., 2004; Morris et al., 2008; Rahman et al.,
2008). People with PD often present with a shuffling gait (short,
low steps) and consequently falls are common (Ashburn et al.,
2001; Wood et al., 2002) with the majority of falls resulting from
a trip (Gazibara et al., 2014).
The minimum toe clearance (mid-swing; MTC) has been consid-
ered an event linked to falls in older adults (Begg et al., 2007;
Barrett et al., 2010) as the risk of making unanticipated contact
with an environmental object/ground is high. A reduced foot clear-
ance (and inadequate limb elevation) and its link with falls risk
was first documented by James Parkinson in his seminal work
characterising the motor symptoms of PD. He commented thatease. J.
2 L. Alcock et al. / Journal of Biomechanics xxx (2018) xxx–xxx‘‘the legs are not raised to that height [when walking], or with that
promptitude which the will directs, so that the utmost care is nec-
essary to prevent frequent falls” (Parkinson, 1917). Fall risk may be
further elevated, particularly for people with PD, due to compro-
mised postural responses (Schoneburg et al., 2013; Park et al.,
2015). Our recent work indicates that whilst MTC is not signifi-
cantly affected in the early stages of PD, a lower MTC is associated
with a reduced gait velocity and a shorter step in older adults with
and without PD (Alcock et al., 2016). Gait alterations in people with
PD are progressive and greater deficits in MTC may be observed
when disease symptoms and motor impairments (i.e. reduced gait
velocity and step length) are more prominent. In support, increas-
ing set velocities using a motorised treadmill resulted in a higher
MTC in people with moderately advanced PD (Cho et al., 2010).
Considering the constant velocity that walking on a motorised
treadmill imposes, it is important to determine whether MTC is
elevated during overground walking when increasing walking
speed.
The aims of this study were to (1) quantify the alterations in
foot clearance when instructed to walk quickly; and (2) evaluate
whether MTC is primarily determined by step length, step velocity
or step time in people with PD. We hypothesised that people with
PD would demonstrate an elevated MTC when asked to walk faster,
and that an increased MTC would be most strongly associated with
longer steps rather than changes in temporal characteristics.2. Methods
2.1. Participants
Thirty-six people with PD (x [SD]age 70.1[9.7]years, height 1.71
[0.08]m and mass 78.2[16.7]kg, 26[72%] males) and 38 controls of
similar age and sex (x [SD]age 72.4[7.8]years, height 1.71[0.09]m
and mass 80.9[13.4]kg, 21[55%] males) underwent clinical gait
analysis as part of the ICICLE-GAIT study (Rochester et al., 2014;
Galna et al., 2015). ICICLE-GAIT is a collaborative study with
ICICLE-PD, an incident cohort study (Incidence of Cognitive Impair-
ment in Cohorts with Longitudinal Evaluation–Parkinson’s disease)
which recruited participants between June 2009 and December
2011 and followed them longitudinally every 18-months (Khoo
et al., 2013). Ethical approval was granted from the local NHS
Research Ethics Committee (Ref: 09/H0906/82) and all participants
provided written informed consent. PD participants were recruited
from the local Movement Disorders Clinic and community
resources were used to recruit controls that had no significant cog-
nitive or movement impairment. People with PD were excluded if
they: presented with parkinsonism syndromes other than PD (i.e.
dementia with Lewy bodies, vascular or drug-induced parkinson-
ism); had multiple system atrophy; progressive supranuclear
palsy; or were unable to communicate sufficiently in English. Data
presented in this study represent a cross-sectional analysis of 54
and 72-month assessments. People with PD were assessed whilst
optimally medicated approximately 1-hour post dopaminergic
medications. PD severity was quantified using the Hoehn and Yahr
stage (H&Y) (Hoehn and Yahr, 1967) and motor function was eval-
uated using Part III of the Movement Disorder Society Unified
Parkinson’s Disease Rating Scale (UPDRS III) (Goetz et al., 2008).
Global cognitive function was quantified using the Montreal Cogni-
tive Assessment (MOCA) due to its increased sensitivity with peo-
ple with PD (Zadikoff et al., 2008).2.2. Protocol
Participants attended the Gait Laboratory wearing comfortable,
flat soled shoes and performed four 10-metre straight walks at aPlease cite this article in press as: Alcock, L., et al. Step length determines min
Biomech. (2018), https://doi.org/10.1016/j.jbiomech.2017.12.002preferred velocity and then four walks at a fast velocity. Trial order
was standardised to avoid the potential carryover effect of fast
walking velocity onto their preferred walking velocity, similar to
protocols used in previous research (Hirasaki et al., 1999; Chui
and Lusardi, 2010). Temporal-spatial gait characteristics were
obtained from a 7-m instrumented walkway (GAITRite, Platinum
model v.4.5, USA, 240 Hz) which was placed centrally within the
walkway to ensure the collection of steady-state gait (2-metres
was covered before and after the mat to allow for acceleration
and deceleration). To measure foot clearance, 14 mm reflective
markers were affixed on the shoe above the dorsum of the second
hallux (toe) and the calcaneus (heel). Trajectories were recorded
using a 14 camera three-dimensional motion capture system sam-
pling at 100 Hz (Bonita 10 cameras, VICON Nexus software
v.2.2.3, Oxford, UK).
2.3. Data analysis
Procedures for data extraction of temporal-spatial and foot
clearance outcomes have been previously described (Alcock et al.,
2016). Briefly, temporal-spatial gait characteristics (gait velocity,
swing velocity, step time, swing time and step length) were
obtained from footfall data and extracted using Microsoft Access
2007. A walk ratio (step length[m]/cadence[steps/min] (Sekiya and
Nagasaki, 1998)) was calculated for each participant and condition
as a velocity-independent index of gait control (Rota et al., 2011).
Marker trajectories were identified and smoothed (Woltring filter,
Mean square error 20 mm, Vicon Nexus v.2.2.3). Foot clearance
outcomes were extracted using a custom-built algorithm imple-
mented in MATLAB (R2015a, Mathworks, Natick, MA) (Alcock
et al., 2016). Vertical displacement of the heel and toe were seg-
mented into gait cycles using a vertical velocity threshold of the
heel trajectory of 250 mm/s to identify heel strike. An offset correc-
tion was applied to account for variation in marker placement and
to ensure that when the foot was flat on the floor (i.e. during mid-
stance), foot clearance was 0 mm. A vertical offset corrected the
heel marker and an angular offset aligned the toe marker with
the heel. The following outcomes were extracted: the maximum
vertical toe displacement during the first and second half of swing;
the minimum vertical toe displacement mid-swing (MTC); and the
peak vertical heel displacement. Peaks were identified when a data
point was larger than the three samples before and after to avoid
erroneous peak detection. All extracted gait cycles where visually
checked prior to further analyses. The take-off (toe) and landing
(heel) gradients were also calculated and defined as the change
in vertical displacement, divided by the change in time (5% of the
start or end of the swing phase, respectively). Variability in foot
clearance was not calculated due to an insufficient number of steps
collected across the four intermittent walks (a minimum of 200
steps have been recommended to be sufficient for calculating vari-
ability (Hamacher et al., 2014)).
2.4. Statistical analysis
A normal distribution was generally confirmed for all group
mean data through visual inspection of the histograms and evaluat-
ing skewness. A General LinearModelwas used to identify the influ-
ence of group (Control vs. PD) and condition (preferred vs. fast
velocity) on temporal-spatial gait and foot clearance (Aim 1). No
significant differences in age, height, mass, sex or global cognition
were observed between groups and thus were not controlled for
in the model. Change in gait and foot clearance between conditions
were also calculated in relative (%) (i.e. step lengthFast  step
lengthPreferred/step lengthFast ⁄ 100) terms. Linear regression was
used to quantify the variance in MTC explained by temporal-
spatial gait characteristics. Two outlierswere identified (one controlimum toe clearance in older adults and people with Parkinson’s disease. J.
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Biomech. (2018), https://doi.org/10.1016/j.jbiomech.2017.12.002and one participant with PD) as caseswith standardised residuals of
>3SD but they did not considerably influence the model (explained
variance or beta coefficient) and remain included in the analysis.
Correlations between temporal-spatial gait and foot clearance are
presented in the Supplementary Material.3. Results
No significant group differences in global cognition (MOCA)
were observed (control group = 26.6[3.3], PD group = 25.7[3.6]).
The PD group presented with mild-to-moderate disease severity,
with 89% (n = 32) of the sample rated as Hoehn and Yahr stage II
and a group mean UPDRS III score of 36.9[12.6]. A similar number
of steps (mean[SD]) were collected for both groups when walking
at a preferred (Control group: 29[8]steps, PD group: 31[9]steps)
and a fast (Control group: 25[6]steps, PD group: 27[8]steps)
velocity.3.1. Alterations in temporal spatial gait and foot clearance during fast
walking
Evaluation of within-group (condition) and between-group
(control vs. PD) differences in temporal-spatial gait characteristics
and foot clearance are presented in Table 1. Barring the walk ratio,
condition had a main effect on all gait and foot clearance outcomes
(Fig. 1), the majority of which significantly increased with faster
velocities (p < .001). In contrast, step time reduced with increasing
velocity (p < .001). Group differences indicated that people with PD
walked more slowly, with a slower swing velocity and reduced
peak toe clearance (late swing) regardless of condition. Interest-
ingly, people with PD walked with a reduced (shorter) swing time
compared to controls at their preferred velocity and with an
increased (longer) swing time compared to controls at their fast
velocity (p = .002). An interaction was observed for the walk ratio
highlighting that people with PD increased their step length rela-
tive to their cadence from preferred to fast gait more so than con-
trols (p = .018). Interactions were also observed for step time,
swing time, gait velocity and swing velocity, revealing a greater
group difference during the fast walking condition.3.2. Temporal-spatial gait determinants of MTC
Correlations demonstrating the relationship between temporal-
spatial gait and foot clearance for both groups and walking condi-
tions are presented in the Supplementary Material. Linear regres-
sion models are presented in Table 2. Cross-sectional analyses
revealed that step length and the walk ratio were consistently
the strongest predictors of MTC for both groups and conditions
(>28.3%). Vector plots revealed that all controls (n = 38,100%) and
the majority of people with PD (n = 33, 92%) increased their step
length from preferred to fast velocity (Fig. 2). Moreover, the major-
ity of the control group (n = 27, 71%) and the PD group (n = 30, 83%)
increased their MTC from preferred to fast velocity.4. Discussion
This study is the first to explore the temporal-spatial mecha-
nisms underpinning MTC in people with PD during overground
walking. These novel findings suggest that step length is strongly
related to MTC in both older adults and people with Parkinson’s
disease and that those who walk faster, with longer steps, also lift
their feet more.imum toe clearance in older adults and people with Parkinson’s disease. J.
Fig. 1. Relative difference (%) in temporal-spatial components of gait and foot clearance parameters with error bars indicating group standard deviation. ESW, MSW and LSW
denote early, mid- and late swing, respectively.
Table 2
Variance in the minimum toe clearance during mid-swing explained by each of the temporal-spatial parameters of gait for both groups and walking conditions.
Preferred gait velocity Fast gait velocity
R2 (%) B p Rank R2 (%) B p Rank
Control Gait velocity 13.3 12.962 .025 3 13.9 9.329 .021 4
n = 38 Swing velocity 12.1 10.675 .032 5 12.0 7.938 .033 5
Step time 2.6 .024 .331 6 8.3 .045 .079 6
Swing time 12.9 .075 .027 4 17.7 .089 .008 3
Step length 31.5 41.437 <.001 2 35.6 37.601 <.001 2
Walk ratio 33.9 4005.956 <.001 1 40.0 4307.769 <.001 1
PD Gait velocity 18.2 14.988 .011 4 8.8 9.861 .079 4
n = 36 Swing velocity 12.5 11.563 .037 5 6.0 8.039 .150 6
Step time 1.6 .022 .472 6 7.2 .049 .113 5
Swing time 21.9 .103 .005 3 22.8 .115 .003 3
Step length 32.0 43.372 <.001 2 28.3 42.763 .001 2
Walk ratio 34.7 4648.797 <.001 1 34.0 4634.574 <.001 1
Temporal-spatial gait characteristics were ranked in order of the magnitude of variance in MTC explained. Italicized values denote significant contributors to regression
models.
4 L. Alcock et al. / Journal of Biomechanics xxx (2018) xxx–xxx4.1. Alterations in foot clearance during fast walking
Providing direct instructions to increase gait velocity may be
considered an attentional strategy similar to being told to focus
on taking ‘‘big steps”. As such the present results are in agreement
with previous work which advocates the use of external (atten-
tional) prompts to increase gait velocity and help to ameliorate
the PD-associated differences in gait (Morris et al., 1994a, 1996).
Previous work suggests that the neurodegeneration in motor con-
trol associated with PD gait evolves with greater changes in spatial
scaling (step length and consequently gait velocity) compared to
step time (Morris et al., 1996; Galna et al., 2015). When instructed
to walk faster, people with PD tended to increase their step length
more so than controls who reduced their swing time more so than
people with PD (evidenced by changes in the walk ratio). In com-
bination, these findings suggest a PD-associated difference in the
temporal-spatial control of walking when increasing gait velocity.
It is important to highlight that there is limited research docu-
menting normative data for the walk ratio, particularly in PD pop-Please cite this article in press as: Alcock, L., et al. Step length determines min
Biomech. (2018), https://doi.org/10.1016/j.jbiomech.2017.12.002ulations, and as such it is unclear how clinically meaningful the
group differences in the walk ratio are.
To date, there remains a lack of knowledge surrounding the
pathogenesis of gait hypokinesia in PD (Morris et al., 1994b) and
the associated alterations in temporal and spatial regulation of
stepping patterns. Locomotor control is complex with multiple
brain regions involved (Hamacher et al., 2015) and we understand
that the basal ganglia and the supplementary motor area interact
to regulate repetitive movements (Seitz and Roland, 1992). Fur-
ther, it is this interaction that is thought to modulate the appropri-
ate step length and cadence for a target gait velocity (Egerton et al.,
2011). Considering the neurodegenerative nature of PD and the
changes known to occur within the basal ganglia due to dopamine
depletion, it is thought that the mechanism governing appropriate
cadence and step length is damaged in people with PD. Evidence
from cueing studies concurs that people with PD are able to
achieve what may be considered a ’normal’ step length (Morris
et al., 1996). This suggests that the inability to internally initiate
and regulate movement contributes to the changes in temporalimum toe clearance in older adults and people with Parkinson’s disease. J.
Fig. 2. Vector plots demonstrating the change in minimum toe clearance with relation to the change in step length between preferred and fast gait velocity conditions in the
control and PD groups. Data are presented for control (n = 38) and PD (n = 35) groups. Data is not included for one PD participant as they displayed 100% unimodal toe
trajectories during the preferred gait velocity condition. The dot denotes the minimum toe clearance and step length obtained during the preferred gait velocity condition.
L. Alcock et al. / Journal of Biomechanics xxx (2018) xxx–xxx 5and spatial control of walking in people with PD. Nevertheless, an
increased gait velocity resulted in the same modifications in MTC
in both groups. It is interesting to note that whilst controls walked
quicker than participants with PD during both conditions, the
group mean change in MTC (mid-swing) when increasing gait
speed (from preferred to fast) was larger in the PD group. Previous
work suggests that smaller alterations to step length in favour of
increasing cadence when walking faster is associated with recur-
rent falls in older adults (Callisaya et al., 2012) and so interventions
improving gait velocity through targeting step length may be
advantageous for increasing MTC and minimising trip risk.
Our recent work indicated that foot clearance was altered in
recently diagnosed participants with PD who present with a
reduced peak toe clearance (late swing) and landing gradient com-
pared to controls (Alcock et al., 2016). In the present study, the peak
toe clearance (late swing) was the only significant group difference
in foot clearance. This was initially surprising given the known gait
impairments associated with PD. However, our previous study
measured foot clearance during a 2-minute continuous walking
protocol (compared to intermittent walks) when people with PD
were walking more slowly (Alcock et al., 2016) and given the posi-
tive association between gait velocity and foot clearance (Cho et al.,
2010; Alcock et al., 2016) the absence of PD-associated differences
may be explained. Moreover, the majority of the group (89%) were
classified as Hoehn and Yahr stage II and as suchwere considered to
be of mild to moderate disease severity. Greater group differences
are likely to emerge as disease symptoms advance.4.2. Step length as a determinant of minimum foot clearance
A reduced magnitude of movement (hypokinesia) is associated
with basal ganglia dysfunction in Parkinson’s disease, suggesting
that defective cortical motor sets result in a miniaturisation of the
gait cycle (Morris et al., 1994b, 1998). Our cross-sectional analyses
revealed that step length and thewalk ratio were the strongest con-
tributors to explaining the variance in MTC in both groups. This
finding has implications for the risk of falls in older adults generally
(both with and without PD) and is in agreement with previous lit-
erature indicating that older adult fallers walk slower with shorter
steps (Guimaraes and Isaacs, 1980) compared to older adult non-
fallerswhowalkwith an increased step length and reduced cadencePlease cite this article in press as: Alcock, L., et al. Step length determines min
Biomech. (2018), https://doi.org/10.1016/j.jbiomech.2017.12.002regardless of walking velocity (Barak et al., 2006). Our data suggests
that people who walk faster lift their feet higher and, more specif-
ically, that people who walk with a longer step also have a higher
MTC. Several studies have confirmed that training exercises can
improve gait metrics in people with PD, particularly step length
(Morris et al., 1994b; Herman et al., 2007, 2009; Bello et al., 2008)
and based on the findings of the present study we would expect
that increased step length would be accompanied by a higher
MTC. However there have been no clinical trials evaluatingwhether
adopting preventative strategies such as improving MTC may min-
imise trip-related falls risk and incidence. Given the potential for
improving gait and foot clearance through therapeutic interven-
tions, it presents as an attractive focus for falls prevention.
Our recent work in people with PD (Lord et al., 2016) concurs
with the research literature in older adults (Abellan Van Kan
et al., 2009; Verghese et al., 2009; Viccaro et al., 2011) that walking
slowly is one of the strongest and most consistent predictors of
falls. The results of the present study suggest that decreased gait
velocity may, at least in part, be associated with reduced foot clear-
ance which contributes to our understanding of the link between
walking slowly and falls risk. Modifying the temporal-spatial con-
trol of walking in people with PD is possible through the imple-
mentation of cues (Nieuwboer et al., 2007) (i.e. visual, auditory,
proprioceptive). Visual cues aim to reconfigure the spatial scaling
of movement (Lewis et al., 2000) and as such they likely provide
increased utility for increasing step length. Moreover, considering
the ability to maintain or increase cadence in people with PD is
retained, auditory cues may be more beneficial later in the disease
course to regulate rhythmical stepping. Redirecting attention dur-
ing gait through the use of direct instructions (e.g. to focus on
walking performance or big steps) can result in significant
improvements in gait velocity and step length in people with PD
(Canning, 2005; Baker et al., 2007). Further work is required to
confirm whether increased gait velocity and improved foot eleva-
tion may be achieved without compromising dynamic stability.4.3. Study limitations
Measuring foot clearance during overground walking ensured
that velocity was not constrained or manipulated (Lai et al.,
2012) or kept constant (Sparrow et al., 2008) as is the case duringimum toe clearance in older adults and people with Parkinson’s disease. J.
6 L. Alcock et al. / Journal of Biomechanics xxx (2018) xxx–xxxtreadmill walking. However, it must be considered that walking in
the real world often presents heightened task demand due to nav-
igating complex surfaces which may vary in height and material.
Remote monitoring of foot clearance in the community is challeng-
ing given the need to model foot displacement relative to the floor
surface. Despite this, the precise measurement of foot clearance is
possible within controlled laboratory environments using a variety
of methods including geometric modelling (Sparrow et al., 2008;
Alcock et al., 2013) and segment digitisation (Startzell and
Cavanagh, 1999; Loverro et al., 2013; Telonio et al., 2013). Mea-
surement technique, analysis procedures and walking protocol uti-
lised (i.e. overground vs. treadmill walking) all influence the
variation in absolute MTC values reported in the literature. The
measurement techniques used in the present study for quantifying
foot clearance are less complex, however they permitted robust
data collection for a large cohort in a longitudinal study without
being burdensome. Furthermore, appropriate steps were taken to
correct the signal for the measurement-induced offset resultant
from variation in marker placement. This study assessed people
with PD who were optimally medicated and wearing their com-
fortable shoes to preserve external validity. However, factors not
controlled for which may have influenced foot clearance include
visual function and correction (Johnson et al., 2007) and shoe sole
geometry (Thies et al., 2015). Another factor influencing MTC is
participant height, and whilst there were no statistical group dif-
ferences in height, we re-ran the General Linear Model analyses
controlling for height as a covariate. Each of the group differences
were retained with the addition of only step length which just
reached statistical significance (p = .042). Consequently, it was
concluded that height did not have a significant influence on the
findings presented and was not included within the present analy-
ses. Lastly, research has proposed alternative MTC measures which
may be linked with falls such as distribution and variability (Begg
et al., 2007; Mills et al., 2008; Sparrow et al., 2008). These mea-
sures were not extracted in the present study due to an insufficient
number of continuous steps collected over the four intermittent
walks (a minimum of 200 steps (100 per foot) is recommended
for calculating variability (Hamacher et al., 2014)).
Given the exploratory nature of this study we elected to not cor-
rect for multiple comparisons and this may be considered a limita-
tion, however in the majority of cases the statistical differences we
observed were considered highly significant (p < .002) and unlikely
to be due to chance. Finally, whilst slower gait velocities have been
successfully used to predict falls in people with PD (Lord et al.,
2016), evidence confirms that this relationship is not linear and
walking too quickly has also been linked to an increased risk of out-
door falls in particular (Quach et al., 2011). Falls are a multifaceted
concern involving many influential factors often simultaneously
and as such it is not advocated that increasing walking speed will
reduce falls risk per se. However, in the context of PD symptoms
including hypokinesia and bradykinesia, walking faster may reduce
trip-risk due to improved foot clearance. Further complementary
work is required to fully appreciate the mechanical underpinning
of altered temporal-spatial gait and foot clearance in people with
PD by quantifying lower limb joint kinetics and electromyography.
5. Conclusions
Attentional strategies offer the utility of increasing gait velocity
and minimising pathology-associated gait deficits over short inter-
mittent walks. This study has demonstrated that reduced MTC is
associated with a smaller step in both older adults and people with
PD. Interventions that target step length may result in increased
MTC however their inclusion as a component of falls prevention
requires further assessment.Please cite this article in press as: Alcock, L., et al. Step length determines min
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